09:01 PM PST | 20 November 2008

About MDRNA

Development Pipeline

Research & Development

Partnerships

News

Investors

Careers



RNAi: From Nastech, MDRNA Launches; Aims for Clinical Trials by Late Next Year RNAi: From Nastech, MDRNA Launches; Aims for Clinical Trials by Late Next Year


Genome Technology, October 2008

At MDRNA we are focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery. We bring optimal value to our partners, shareholders and ultimately to patients through the discovery and development of RNAi-based therapeutics against human diseases including critical unmet medical needs in areas such as oncology, inflammation and metabolic disorders.

13 November 2008: MDRNA, Inc. Announces Third Quarter 2008 Financial Results
06 November 2008: MDRNA, Inc. to Hold Third Quarter 2008 Earnings Conference Call on Thursday, November 13, 2008, at 4:30 p.m. Eastern Time
View MDRNA's Drug Development Technology



2007 Annual Report



Join the MDRNA Team!



  © 2008 MDRNA   Legal Notice
Site Map  Contact     Search  

built@zoomedia